Your browser doesn't support javascript.
loading
A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design.
Freedland, Stephen J; De Giorgi, Ugo; Gleave, Martin; Rosbrook, Brad; Shen, Qi; Sugg, Jennifer; Haas, Gabriel P; Shore, Neal D.
  • Freedland SJ; Division of Urology, Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA stephen.freedland@cshs.org.
  • De Giorgi U; Section of Urology, Durham VA Medical Center, Durham, North Carolina, USA.
  • Gleave M; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Rosbrook B; Department of Urologic Sciences, Vancouver Prostate Centre, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Shen Q; Department of Global Biometrics and Data Management, Pfizer, New York, New York, USA.
  • Sugg J; Department of Product Development, Pfizer, New York, New York, USA.
  • Haas GP; Department of Biostatistics, Astellas Pharma US, Northbrook, Illinois, USA.
  • Shore ND; Astellas Pharma Global Development, Northbrook, Illinois, USA.
BMJ Open ; 11(8): e046588, 2021 08 12.
Article en En | MEDLINE | ID: mdl-34385241
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2021 Tipo del documento: Article